Paliperidone

A new atypical antipsychotic or more of the same?

Research output: Contribution to journalShort SurveyOtherpeer-review

Abstract

Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.

Original languageEnglish
Pages (from-to)68-69
Number of pages2
JournalMedicine Today
Volume10
Issue number7
Publication statusPublished - Jul 2009

Cite this

@article{e67e48e9930b433687586032655d01ea,
title = "Paliperidone: A new atypical antipsychotic or more of the same?",
abstract = "Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.",
author = "Judy Hope and Nicholas Keks",
year = "2009",
month = "7",
language = "English",
volume = "10",
pages = "68--69",
journal = "Medicine Today",
issn = "1443-430X",
publisher = "Medicine Today",
number = "7",

}

Paliperidone : A new atypical antipsychotic or more of the same? / Hope, Judy; Keks, Nicholas.

In: Medicine Today, Vol. 10, No. 7, 07.2009, p. 68-69.

Research output: Contribution to journalShort SurveyOtherpeer-review

TY - JOUR

T1 - Paliperidone

T2 - A new atypical antipsychotic or more of the same?

AU - Hope, Judy

AU - Keks, Nicholas

PY - 2009/7

Y1 - 2009/7

N2 - Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.

AB - Paliperidone has now been approved for the treatment of schizophrenia. It is an active metabolite of risperidone in an extended-release formulation.

UR - http://www.scopus.com/inward/record.url?scp=68249103843&partnerID=8YFLogxK

M3 - Short Survey

VL - 10

SP - 68

EP - 69

JO - Medicine Today

JF - Medicine Today

SN - 1443-430X

IS - 7

ER -